tiprankstipranks
Advertisement
Advertisement
TG Therapeutics Files Procedural 8-K on Financial Obligation
PremiumCompany AnnouncementsTG Therapeutics Files Procedural 8-K on Financial Obligation
2M ago
TG Therapeutics secures additional $500M in non-dilutive capital
Premium
The Fly
TG Therapeutics secures additional $500M in non-dilutive capital
2M ago
TG Therapeutics board expands share repurchase program to $300M
Premium
The Fly
TG Therapeutics board expands share repurchase program to $300M
2M ago
Buy Rating Backed by Briumvi’s Strong Commercial Ramp, Growing CD20 Market Share, and Visible Long‑Term Revenue Expansion
PremiumRatingsBuy Rating Backed by Briumvi’s Strong Commercial Ramp, Growing CD20 Market Share, and Visible Long‑Term Revenue Expansion
3M ago
TG Therapeutics sees FY26 revenue $875M-$900M, consensus $897.64M
Premium
The Fly
TG Therapeutics sees FY26 revenue $875M-$900M, consensus $897.64M
3M ago
TG Therapeutics reports Q4 EPS 14c, consensus 33c
Premium
The Fly
TG Therapeutics reports Q4 EPS 14c, consensus 33c
3M ago
Buy Rating on Briumvi Driven by Strong Commercial Momentum, 2026 Growth Outlook, and Underappreciated Autoimmune Pipeline Optionality
PremiumRatingsBuy Rating on Briumvi Driven by Strong Commercial Momentum, 2026 Growth Outlook, and Underappreciated Autoimmune Pipeline Optionality
4M ago
TG Therapeutics price target raised to $39 from $37 at Goldman Sachs
Premium
The Fly
TG Therapeutics price target raised to $39 from $37 at Goldman Sachs
4M ago
Midday Fly By: Big banks report mixed quarterly results
Premium
The Fly
Midday Fly By: Big banks report mixed quarterly results
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100